Antiverse
Revolutionising Drug Discovery Through Artificial Intelligence
Antiverse is building a world-first computational antibody drug discovery platform to predict antibody-antigen binding and provide antibody drug candidates.
Currently drug discovery is a case of trial and error based on informed guesses. Meaning that, drug discovery times can be lengthy and costly. For many outbreaks such as ebola, time isn’t a commodity and lives are lost every minute of the drug discovery process.
Revolutionising Drug Discovery Through Artificial Intelligence
Antiverse aims to revolutionise drug discovery by applying cutting-edge artificial intelligence techniques. CEMET created a neural network which predicts the complementary amino-acid sequence of a compatible, strongly-binding antibody. The result: faster and highly targeted drug-discovery that reduces the time typically required for antibody therapeutics discovery by 3 to 18 months.